ArticleJournal of addiction medicine2012
Financial factors and the implementation of medications for treating opioid use disorders.
Article in Journal of addiction medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- Routes of non-traditional entry into buprenorphine treatment programs.Substance abuse treatment, prevention, and policy · 2020Pooled it
- Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.Journal of substance abuse treatment · 2014Pooled it
- The payer's role in addressing the opioid epidemic: It's more than money.Journal of substance abuse treatment · 2019Trial
- Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trial.Implementation science : IS · 2013Trial
- Association Between Integrated Treatment Services and Access to Detoxification and MOUD Across US Treatment Facilities.The journal of behavioral health services & research · 2026Article
- Characterizing intersystem and community values to enhance opioid use disorder treatments: Communities That Heal intervention in New York.The International journal on drug policy · 2025Article
- Dissemination of health content through social networks: YouTube and opioid use disorders.Journal of substance use and addiction treatment · 2024Review
- Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.PLoS computational biology · 2024Article
- Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.medRxiv : the preprint server for health sciences · 2023Article
- A qualitative investigation of addiction counselors' perceptions and experiences implementing an open-access model for treating opioid use disorder.Journal of substance abuse treatment · 2021Article
- The use of off-label medications in substance abuse treatment programs.Substance abuse · 2020Article
- Comparing Canadian and United States opioid agonist therapy policies.The International journal on drug policy · 2019Article
- Overcoming Barriers to Adopting and Implementing Pharmacotherapy: the Medication Research Partnership.The journal of behavioral health services & research · 2019Article
- The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.Harm reduction journal · 2018Article
- Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.Annual review of public health · 2018Review
- Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change.Journal of studies on alcohol and drugs · 2017Article
- Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.The American journal on addictions · 2017Article
- Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use.Journal of substance abuse treatment · 2016Article
- The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.Journal of studies on alcohol and drugs · 2016Article
- Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.Psychiatric services (Washington, D.C.) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
objectivesDespite the established effectiveness of pharmacotherapies for treating opioid use disorders, implementation of medications for addiction treatment (MAT) by specialty treatment programs is limited. This research examined relationships between organizational factors and the program-level implementation of MAT, with attention paid to specific sources of funding, organizational structure, and workforce resources.
methodsFace-to-face structured interviews were conducted in 2008 to 2009 with administrators of 154 community-based treatment programs affiliated with the National Institute on Drug Abuse's Clinical Trials Network; none of these programs exclusively dispensed methadone without offering other levels of care. Implementation of MAT was measured by summing the percentages of opioid patients receiving buprenorphine maintenance, methadone maintenance, and tablet naltrexone. Financial factors included the percentages of revenues received from Medicaid, private insurance, criminal justice, the Federal block grant, state government, and county government. Organizational structure and workforce characteristics were also measured.
resultsImplementation of MAT for opioid use disorders was low. Greater reliance on Medicaid was positively associated with implementation after controlling for organizational structure and workforce measures, whereas the association for reliance on criminal justice revenues was negative.
conclusionsThe implementation of MAT for opioid use disorders by specialty addiction treatment programs may be facilitated by Medicaid but may be impeded by reliance on funding from the criminal justice system. These findings point to the need for additional research that considers the impact of organizational dependence on different types of funding on patterns of addiction treatment practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.